Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Accounts Payables (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Accounts Payables for 5 consecutive years, with $99.3 million as the latest value for Q4 2022.

  • Quarterly Accounts Payables rose 7.05% to $99.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $99.3 million through Dec 2022, up 7.05% year-over-year, with the annual reading at $102.4 million for FY2022, 10.03% up from the prior year.
  • Accounts Payables for Q4 2022 was $99.3 million at NovaBridge Biosciences, up from $92.8 million in the prior quarter.
  • The five-year high for Accounts Payables was $99.3 million in Q4 2022, with the low at $9.8 million in Q4 2018.
  • Average Accounts Payables over 5 years is $65.1 million, with a median of $84.6 million recorded in 2020.
  • The sharpest move saw Accounts Payables skyrocketed 296.54% in 2019, then grew 7.05% in 2022.
  • Over 5 years, Accounts Payables stood at $9.8 million in 2018, then surged by 296.54% to $38.8 million in 2019, then surged by 117.93% to $84.6 million in 2020, then grew by 9.72% to $92.8 million in 2021, then rose by 7.05% to $99.3 million in 2022.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $99.3 million, $92.8 million, and $84.6 million for Q4 2022, Q4 2021, and Q4 2020 respectively.